Microwave-assisted one-pot multicomponent synthesis of steroidal pyrido[2,3-d]pyrimidines and their possible implications in drug development

Steroids. 2023 Feb:190:109154. doi: 10.1016/j.steroids.2022.109154. Epub 2022 Dec 12.

Abstract

Protein misfolding can lead to fibrillar and non-fibrillar deposits which are the signs of countless human diseases. A promising strategy for the prevention of such diseases is the inhibition of protein aggregation, and the most crucial step toward effective prevention is the development of small molecules having the potential for protein-aggregation inhibition. In this search, a series of novel steroidal pyrido[2,3-d]pyrimidines have been synthesized employing steroidal ketone, substituted aldehydes, and 2,6-diaminopyrimidin-4(3H)-one through the microwave-assisted one-pot multicomponent methodology. The aggregation inhibition potential of newly synthesized compounds was evaluated on human lysozyme (HLZ). All the synthesized compounds were found to be efficient in the inhibition of protein aggregation in carefully designed in vitro experiments. Moreover, molecular docking studies also determine the binding interactions between all the synthesized compounds and native HLZ through hydrogen bonding. The structures of synthesized compounds were also elucidated using various spectroscopic techniques.

Keywords: Drug development; Microwave; Molecular docking; Multicomponent; Steroidal pyridopyrimidines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Development
  • Humans
  • Microwaves*
  • Molecular Docking Simulation
  • Protein Aggregates
  • Pyrimidines*
  • Steroids / chemistry

Substances

  • Pyrimidines
  • Protein Aggregates
  • Steroids